P05106 (ITB3_HUMAN) Homo sapiens (Human)
Integrin beta-3 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
112 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structures of full-length integrin alphaIIbbeta3 in native lipids complexed with modified t… |
Heteromer P08514; | 100 | 3×NAG; 2×NAG; 1×NAG; 7×CA; 5×NAG; 1×MG; 1×A1A5G; 2×CLR; | |||
| Cryo-EM Structures of Full-length Integrin alphaIIbbeta3 in Native Lipids |
Heteromer P08514; | 100 | 2×NAG; 1×NAG; 1×NAG; 1×NAG; 7×CA; 6×NAG; 2×CLR; 1×MG; | |||
| Full length Integrin AlphaIIbBeta3 in inactive state |
Heteromer P08514; | 100.0 | 1×NAG; 1×NAG; 2×NAG; 7×CA; 3×NAG; 1×MG; | |||
| Crystal structure of the complete integrin alhaVbeta3 ectodomain plus an Alpha/beta transmembrane f… |
Heteromer P06756; | 100 | 1×NAG; 6×NAG; 1×NAG; 2×NAG; 5×NAG; 6×CA; | |||
| Re-refinement of alpha V beta 3 structure |
Heteromer P06756; | 100 | 1×NAG; 9×NAG; 1×NAG; 1×NAG; 7×CA; 4×NAG; 1×NA; | |||
| Crystal structure of integrin alpha V beta 3 with coil-coiled tag. |
Heteromer P06756; | 100.0 | 4×NAG; 3×NAG; 1×NAG; 4×NAG; 1×NAG; 6×CA; 2×NAG; 6×SO4; 7×CL; 1×NI; | |||
| Structure of complete ectodomain of integrin aIIBb3 |
Heteromer P08514; | 99.85 | 2×NAG; 1×NAG; 1×NAG; 1×NAG; 7×CA; 2×NAG; 1×IMD; 1×MG; | |||
| A novel adaptation of the integrin PSI domain revealed from its crystal structure |
Heteromer P06756; | 99.17 | 4×NAG; 3×NAG; 5×NAG; 6×CA; | |||
| Integrin AlphaVBeta3 ectodomain bound to an antagonistic tenth domain of Fibronectin |
Heteromer P02751; P06756; | 100 | 4×NAG; 1×NAG; 1×NAG; 8×NAG; 8×MN; 1×NA; 2×GOL; | |||
| Integrin AlphaVBeta3 ectodomain bound to Hr10 variant of the 10th domain of Fibronectin. |
Heteromer P02751; P06756; | 100 | 5×NAG; 1×NAG; 1×NAG; 7×NAG; 8×MN; | |||
| Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D |
Heteromer P06756; P12071; | 100 | 2×NAG; 5×NAG; 1×NAG; 1×NAG; 4×NAG; 8×MN; | |||
| Integrin alphaVBeta3 in complex with EETI-II 2.5F |
Heteromer P06756; P12071; | 100 | 2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN; 1×CL; | |||
| Integrin AlphaVBeta3 ectodomain bound to the tenth domain of Fibronectin with the IAKGDWND motif |
Heteromer P02751; P06756; | 100 | 2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN; | |||
| Integrin AlphaVBeta3 ectodomain bound to the tenth domain of Fibronectin |
Heteromer P02751; P06756; | 100 | 2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN; | |||
| Three-dimensional reconstruction of intact human integrin alphaIIbbeta3 in a phospholipid bilayer n… |
Heteromer P08514; | 99.85 | 2×NAG; 1×NAG; 1×NAG; 1×NAG; 2×NAG; | |||
| The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human alpha-V beta-3 Integrin… |
Heteromer P06756; | 100 | ||||
| Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161 |
Heteromer P06756; | 100 | 4×NAG; 1×NAG; 1×NAG; 8×NAG; 8×MN; 1×JUY; | |||
| AlphaVBeta3 integrin in complex with monoclonal antibody FAB fragment. |
Heteromer P06756; | 100 | 1×NAG; 1×NAG; 2×NAG; 3×NAG; 3×NAG; 5×MN; 2×NO3; | |||
| The Extracellular Domain of Integrin AlphaIIbBeta3 in Intermediate State |
Heteromer P08514; | 100.0 | 2×NAG; 1×NAG; 6×CA; 2×NAG; 1×MG; | |||
| Human alpha-V beta-3 Integrin (intermediate conformation) in complex with the therapeutic antibody … |
Heteromer P06756; | 100 | ||||
| Cryo-EM structure of integrin ITGAV/ITGB3 complex, conformation 1 |
Heteromer P06756; | 100 | ||||
| CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3 |
Heteromer P06756; | 99.07 | 4×NAG; 3×NAG; 4×NAG; 6×CA; | |||
| CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGA… |
Heteromer P06756; | 99.07 | 4×NAG; 3×NAG; 4×NAG; 8×MN; | |||
| CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+ |
Heteromer P06756; | 99.07 | 4×NAG; 3×NAG; 4×NAG; 6×MN; | |||
| Cryo-EM structure of integrin ITGAV/ITGB3 complex, conformation 5 |
Heteromer P06756; | 100 | ||||
| Cryo-EM structure of integrin ITGAV/ITGB3 complex, conformation 4 |
Heteromer P06756; | 100.0 | ||||
| Structure of the semi-extended AlphaIIbBeta3 in complex with R21D10 Fab |
Heteromer P08514; | 100 | 6×CA; 1×MG; | |||
| Cryo-EM Structures of Full-Length Integrin alphaIIbbeta3 in Native Lipids Complexed with Tirofiban |
Heteromer P08514; | 100.0 | 2×NAG; 2×NAG; 1×NAG; 6×CA; 1×MG; 1×AGG; | |||
| Cryo-EM structure of integrin ITGAV, ITGB3 and CYCLO (RGDFK) complex, conformation 1 |
Heteromer P06756; | 100.0 | 1×A1LU7; | |||
| Cryo-EM structure of integrin ITGAV/ITGB3 complex, conformation 2 |
Heteromer P06756; | 100 | ||||
| Cryo-EM structure of integrin ITGAV, ITGB3 and Cilengitide TFA complex, conformation 2 |
Heteromer P06756; | 100.0 | 1×A1LU4; | |||
| Cryo-EM structure of integrin ITGAV, ITGB3 and Cilengitide TFA complex, conformation 1 |
Heteromer P06756; | 100 | 1×A1LU4; | |||
| Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×GOL; 2×SO4; 4×CA; 3×MN; | |||
| Integrin alpha IIB beta3 complex with BMS4-3 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×MWO; | |||
| Integrin alpha IIB beta3 complex with GR144053 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 7×SO4; 4×CA; 3×MN; 1×NAG; 1×MJX; | |||
| A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ f… |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×CL; 1×MG; 1×NAG; | |||
| Integrin alpha IIB beta3 complex with BMS compound 4 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×SO4; 6×CA; 1×MG; 1×NAG; 1×I7R; | |||
| The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does… |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 2×GOL; 3×SO4; 1×MG; 1×NAG; | |||
| Integrin alpha IIB beta3 complex with BMS4-1 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×M6K; | |||
| The Closed Headpiece of Integrin alphaIIB beta3 and its Complex with an alpahIIB beta3 -Specific An… |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 7×GOL; 4×SO4; 1×MG; 1×NAG; | |||
| Integrin alphaIIbbeta3 in complex with sibrafiban |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×MG; 1×NAG; 1×XQS; | |||
| Integrin alpha IIB beta3 complex with gantofiban |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×MV8; | |||
| Integrin alpha IIB beta3 complex with BMS4.2 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×NJF; | |||
| The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does… |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 1×NIF; 7×GOL; 9×SO4; 1×MG; 1×NAG; | |||
| Integrin alpha IIB beta3 complex with lamifiban |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×CL; 1×MG; 1×NAG; 1×NB9; | |||
| Integrin alpha IIB beta3 complex with UR2922 in Mn2+ |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×SO4; 4×CA; 1×GOL; 3×MN; 1×NAG; 1×I1F; | |||
| Integrin alpha IIB beta3 complex with UR2922 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 5×SO4; 1×MG; 1×NAG; 1×I1F; | |||
| A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ f… |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 1×RC2; 4×SO4; 1×NAG; 1×CL; | |||
| Integrin alpha IIB beta3 complex with EF5154 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 3×SO4; 1×MG; 1×NAG; 1×IR7; | |||
| Integrin alpha IIB beta3 complex with Tirofiban |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 2×NAG; 5×SO4; 1×MG; 1×AGG; | |||
| Integrin alpha IIB beta3 complex with lamifiban (Mn) |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×NB9; | |||
| Integrin alpha IIB beta3 complex with sibrafiban (Mn) |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 3×SO4; 4×CA; 2×GOL; 3×MN; 1×NAG; 1×XQS; | |||
| Integrin alphaIIbbeta3 in complex with AGDV-NH2 peptide |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×CA; 4×SO4; 1×GOL; 3×MN; 1×NAG; | |||
| Integrin alpha IIB beta3 complex with BMS compound 4 in Mn2+ |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×I7R; | |||
| Integrin alphaIIbbeta3 in complex with Ro-435054 |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 3×SO4; 1×GOL; 5×CA; 1×MG; 1×NAG; 1×5YB; | |||
| Integrin alpha IIB beta3 complex with fradafiban |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×MG; 1×NAG; 1×MWX; 1×CL; | |||
| Integrin alpha IIB beta3 complex with Eptifibatide |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 6×CA; 2×SO4; 1×MG; 1×NAG; | |||
| Integrin alpha IIB beta3 complex with roxifiban (Mn/Ca) |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×N9U; | |||
| Integrin alpha IIB beta3 complex with lotrafiban |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 5×CA; 1×MG; 1×NAG; 1×MWI; | |||
| Integrin alpha IIB beta3 complex with a gantofiban analog |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 3×SO4; 4×CA; 2×MN; 1×NAG; 1×NJ9; | |||
| Integrin alpha IIB beta3 complex with fradafiban (Mn/Ca) |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 5×SO4; 1×GOL; 4×CA; 3×MN; 1×NAG; 1×MWX; 1×CL; | |||
| Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×SO4; 4×CA; 3×MN; 1×NAG; | |||
| Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 14×SO4; 6×CA; 1×MG; 1×NAG; | |||
| Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×GOL; 3×SO4; 4×CA; 1×CL; 3×MN; 1×NAG; | |||
| Integrin alpha IIB beta3 complex with cRGDfV |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×CA; 8×GOL; 6×SO4; 3×MN; 1×NAG; | |||
| Integrin alphaIIbbeta3 in complex with AGDV peptide |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 4×CA; 5×SO4; 1×GOL; 3×MN; 1×NAG; | |||
| Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 2×SO4; 4×CA; 3×MN; 1×NAG; | |||
| Integrin alphaIIbbeta3 in complex with AGDV peptide |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 2×SO4; 4×CA; 3×MN; 1×NAG; | |||
| Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 3×SO4; 4×CA; 3×MN; 1×NAG; | |||
| Cryo-EM structure of integrin ITGAV, ITGB3 and CYCLO (RGDFK) complex, conformation 2 |
Heteromer P06756; | 100.0 | 1×A1LU7; | |||
| Integrin AlphaIIbBeta3 Headpiece Bound to a chimeric Fibrinogen Gamma chain peptide, LGGAKQRGDV |
Heteromer P02679; P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | |||
| Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV |
Heteromer P02679; P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | |||
| Integrin AlphaIIbBeta3 Headpiece Bound to a Chimeric Fibrinogen Gamma chain peptide, HHLGGAKQRGDV |
Heteromer P02679; P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | |||
| Re-refinement of Integrin AlphaIIbBeta3 Headpiece |
Heteromer P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×CAC; 1×MG; | |||
| Re-refinement of Integrin AlphaIIbBeta3 Headpiece |
Heteromer P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×CAC; 1×MG; | |||
| Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide,LGGAKQAGDV |
Heteromer P02679; P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | |||
| Structure of headpiece of integrin aIIBb3 in open conformation |
Heteromer P08514; | 100.0 | 1×NAG; 6×CA; 3×NAG; 2×MG; 1×CAC; | |||
| Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Tirofiban |
Heteromer P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×AGG; 1×MG; | |||
| Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Eptifibatide |
Heteromer P08514; | 100.0 | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | |||
| Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist L-739758 |
Heteromer P08514; | 100.0 | 1×NAG; 1×NAG; 2×MG; 2×GOL; 6×CA; 3×NAG; 1×180; | |||
| Human alpha-V beta-3 Integrin (open conformation) in complex with the therapeutic antibody LM609 |
Heteromer P06756; | 100 | ||||
| Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the plate… |
Heteromer P08514; | 100 | 1×NAG; 6×CA; 2×NAG; 1×CAC; 1×MG; | |||
| Integrin AlphaIIbBeta3-PT25-2 Complex |
Heteromer P08514; | 100 | 1×NAG; 1×NAG; 1×NAG; 6×CA; 1×NAG; 1×MG; | |||
| Structure of the integrin AlphaIIbBeta3-Abciximab complex |
Heteromer P08514; | 100 | 6×CA; 1×MG; | |||
| Cryo-EM Structures of Full-length Integrin alphaIIbbeta3 in Native Lipids complexed with Eptifibati… |
Heteromer P08514; | 100.0 | 2×NAG; 1×NAG; 2×NAG; 6×CA; 1×MG; | |||
| Cryo-EM structure of Integrin AVB3 |
Heteromer P06756; | 100.0 | ||||
| Platelet integrin ALFAIIB-BETA3 transmembrane-cytoplasmic heterocomplex |
Heteromer P08514; | 100 | ||||
| The structure of Filamin repeat 21 bound to integrin |
Heteromer P08514; P21333; | 95.75 | ||||
| Platelet integrin alfaIIb-beta3 cytoplasmic domain |
Heteromer P08514; | 100 | ||||
| Integrin alphaIIb-beta3 transmembrane complex |
Heteromer P08514; | 97.67 | ||||
| Structure of the Integrin alphaIIb-beta3(A711P) Transmembrane Complex |
Heteromer P08514; | 92.86 | ||||
| Structure of the integrin aIIb(W968V)b3 transmembrane complex |
Heteromer P08514; | 97.62 | ||||
| Shc-PTB:biphosphorylated integrin beta3 cytoplasmic tail complex (1:1) |
Heteromer P29353; | 100 | ||||
| Solution Structure of the Membrane Proximal Regions of alpha-IIb and beta-3 Integrins |
Heteromer P08514; | 100 | ||||
| Solution Structure of the Membrane Proximal Regions of alpha-IIb and beta-3 Integrins |
Heteromer P08514; | 100 | ||||
| CRYSTAL STRUCTURE OF AN INTEGRIN BETA3-TALIN CHIMERA |
Heteromer P54939; | 100 | ||||
| CRYSTAL STRUCTURE OF AN INTEGRIN BETA3-TALIN CHIMERA |
Heteromer P54939; | 100 | ||||
| The structure of HLA-DRA, DRB3*0101 (DR52a) with bound platelet integrin peptide associated with fe… |
Heteromer P01903; P79483; | 90.91 | ||||
| Crystal structure of an integrin beta3-talin chimera |
Heteromer P54939; | 100 | ||||
| Crystal structure of SH3:RGT complex |
Heteromer P12931; | 100 | ||||
| Structure of a single-chain beta3 integrin | monomer | 100 | 2×MG; 4×NAG; | |||
| Crystal structure of an extended b3 integrin P33 | monomer | 99.08 | 1×CA; 2×NAG; 2×GOL; | |||
| Crystal structure of an extended beta3 integrin P33 | monomer | 99.08 | 1×MG; 2×NAG; | |||
| Crystal structure of an extended b3 integrin L33 | monomer | 100 | 1×GOL; 3×NAG; 1×CA; | |||
| Integrin beta3 subunit in a disulfide linked alphaIIb-beta3 cytosolic domain | monomer | 100 | ||||
| Monophosphorylated (747pY) beta3 integrin cytoplasmic tail under aqueous conditions | monomer | 100 | ||||
| NMR Structure of the integrin B3 cytoplasmic domain in DPC micelles | monomer | 100 | ||||
| monophosphorylated (747pY) beta3 integrin cytoplasmic tail under membrane mimetic conditions | monomer | 100 | ||||
| Biphosphorylated (747pY, 759pY) beta3 integrin cytoplasmic tail under membrane mimetic conditions | monomer | 100 | ||||
| Structure of the Integrin beta3 (A711P,K716A) Transmembrane Segment | monomer | 93.02 | ||||
| Micelle-embedded integrin beta3 transmembrane segment | monomer | 97.62 | ||||
| Bicelle-embedded integrin beta3 transmembrane segment | monomer | 97.62 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8t2v.1.B | monomer | 0.76 | 2×CA; 1×MG; | 100.00 | ||
| 9der.1.B | monomer | 0.73 | 2×CA; 1×MG; | 100.00 | ||
| 6bxj.1.A | monomer | 0.63 | 78.28 | |||
| 6bxb.1.A | monomer | 0.53 | 1×CA; | 72.51 | ||
8 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 7kn0.1.B | monomer | 0.75 | 90.48 | |||
| Isoform 2 | 8gcd.1.B | monomer | 0.72 | 2×CA; 1×MG; | 98.84 | ||
| Isoform 2 | 6bxj.1.A | monomer | 0.62 | 78.28 | |||
| Isoform 2 | 6bxb.1.A | monomer | 0.53 | 1×CA; | 72.51 | ||
| Isoform 3 | 7kn0.1.B | monomer | 0.74 | 90.48 | |||
| Isoform 3 | 8gcd.1.B | monomer | 0.73 | 2×CA; 1×MG; | 98.21 | ||
| Isoform 3 | 6bxj.1.A | monomer | 0.62 | 78.28 | |||
| Isoform 3 | 6bxb.1.A | monomer | 0.53 | 1×CA; | 72.28 | ||